{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:53:15Z","timestamp":1792443195377,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["arthroplastyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Arthroplasty"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.arth.2025.04.079","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T11:27:17Z","timestamp":1746530837000},"page":"2671-2678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cefazolin Is Associated With a Lower Periprosthetic Joint Infection Risk than Alternative Antibiotic Regimens Following Total Hip Arthroplasty"],"prefix":"10.1016","volume":"40","author":[{"given":"Brian J.","family":"Carter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kranti C.","family":"Rumalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8905-9264","authenticated-orcid":false,"given":"Isaac L.","family":"Sontag-Milobsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin R.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda I.","family":"Suleiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam I.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arth.2025.04.079_bib1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0140-6736(18)31665-9","article-title":"How long does a hip replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up","volume":"393","author":"Evans","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.arth.2025.04.079_bib2","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1302\/0301-620X.104B9.BJJ-2022-0116.R1","article-title":"Estimating incidence rates of periprosthetic joint infection after hip and knee arthroplasty for osteoarthritis using linked registry and administrative health data","volume":"104-B","author":"Jin","year":"2022","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2025.04.079_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.artd.2017.05.003","article-title":"Infection burden in total hip and knee arthroplasties: an international registry-based perspective","volume":"3","author":"Springer","year":"2017","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2025.04.079_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.arth.2012.02.022","article-title":"Economic burden of periprosthetic joint infection in the United States","volume":"27","author":"Kurtz","year":"2012","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.079_bib5","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/j.arth.2018.12.024","article-title":"Mortality during total hip periprosthetic joint infection","volume":"34","author":"Natsuhara","year":"2019","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.079_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2106\/00004623-200704000-00012","article-title":"Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030","volume":"89","author":"Kurtz","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.079_bib7","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2106\/JBJS.N.01141","article-title":"Prevalence of total hip and knee replacement in the United States","volume":"97","author":"Maradit","year":"2015","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.079_bib8","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2106\/JBJS.L.00789","article-title":"Periprosthetic joint infection increases the risk of one-year mortality","volume":"95","author":"Zmistowski","year":"2013","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.079_bib9","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3390\/jcm11061657","article-title":"Long term results of two-stage revision for chronic periprosthetic hip infection: a multicenter study","volume":"11","author":"Kildow","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.arth.2025.04.079_bib10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7150\/jbji.35428","article-title":"Prosthetic-joint infections: mortality over the last 10 years","volume":"4","author":"Fischbacher","year":"2019","journal-title":"J Bone Jt Infect"},{"key":"10.1016\/j.arth.2025.04.079_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2106\/JBJS.17.01103","article-title":"Long-term results of a 2-stage exchange protocol for periprosthetic joint infection following total hip arthroplasty in 164 hips","volume":"101","author":"Petis","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.079_bib12","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.arth.2023.10.040","article-title":"Validation of the incidence of reported periprosthetic joint infections in total hip and knee arthroplasty in the Dutch arthroplasty register","volume":"39","author":"van Veghel","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.079_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/17453674.2019.1708655","article-title":"Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register","volume":"91","author":"Kuijpers","year":"2020","journal-title":"Acta Orthop"},{"key":"10.1016\/j.arth.2025.04.079_bib14","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1302\/2046-3758.66.BJR-2017-0003.R1","article-title":"Revision for prosthetic joint infection following hip arthroplasty: evidence from the National Joint Registry","volume":"6","author":"Lenguerrand","year":"2017","journal-title":"Bone Joint Res"},{"key":"10.1016\/j.arth.2025.04.079_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ajic.2010.03.017","article-title":"Patients\u2019 experiences of acquiring a deep surgical site infection: an interview study","volume":"38","author":"Andersson","year":"2010","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.arth.2025.04.079_bib16","doi-asserted-by":"crossref","DOI":"10.5435\/JAAOS-D-19-00405","article-title":"Diagnosis and prevention of periprosthetic joint infections","volume":"28","author":"Tubb","year":"2020","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2025.04.079_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1302\/0301-620X.101B6.BJJ-2018-1407.R1","article-title":"2019 John Charnley Award: increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis","volume":"101-B","author":"Wyles","year":"2019","journal-title":"Bone Joint J"},{"key":"10.1016\/j.arth.2025.04.079_bib18","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1302\/2633-1462.31.BJO-2021-0051.R1","article-title":"Cefazolin remains the linchpin for preventing acute periprosthetic joint infection following primary total knee arthroplasty","volume":"3","author":"Buchalter","year":"2022","journal-title":"Bone Jt Open"},{"key":"10.1016\/j.arth.2025.04.079_bib19","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2106\/JBJS.21.00445","article-title":"Antibiotic prophylaxis with cefazolin is associated with lower shoulder periprosthetic joint infection rates than non-cefazolin alternatives","volume":"104","author":"Marigi","year":"2022","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.079_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jor.2018.01.052","article-title":"Survey of shoulder arthroplasty surgeons\u2019 methods for infection avoidance of Propionibacterium","volume":"15","author":"Parada","year":"2018","journal-title":"J Orthop"},{"key":"10.1016\/j.arth.2025.04.079_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2106\/JBJS.18.00336","article-title":"Perioperative antibiotic prophylaxis in total joint arthroplasty: a single dose is as effective as multiple doses","volume":"101","author":"Tan","year":"2019","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.arth.2025.04.079_bib22","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.artd.2022.02.019","article-title":"Increased rate of early periprosthetic joint infection in total hip arthroplasty with the use of alternatives to cefazolin despite additional gram-negative coverage","volume":"14","author":"Ortiz","year":"2022","journal-title":"Arthroplast Today"},{"key":"10.1016\/j.arth.2025.04.079_bib23","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jse.2023.10.029","article-title":"Non-cefazolin antibiotic prophylaxis is associated with higher rates of elbow periprosthetic joint infection","volume":"33","author":"Nieboer","year":"2024","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.arth.2025.04.079_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s42836-023-00222-2","article-title":"Addition of vancomycin to cefazolin is often unnecessary for preoperative antibiotic prophylaxis during total joint arthroplasties","volume":"6","author":"Bains","year":"2024","journal-title":"Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.079_bib25","doi-asserted-by":"crossref","DOI":"10.5435\/JAAOS-D-22-00122","article-title":"Documented penicillin allergies should not preclude use of preoperative cefazolin in hip and knee arthroplasty","volume":"31","author":"Kurcz","year":"2023","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.arth.2025.04.079_bib26","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.arth.2024.04.058","article-title":"Perioperative cefazolin for total joint arthroplasty patients who have a penicillin allergy: is it safe?","volume":"39","author":"Bukowski","year":"2024","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.079_bib27","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/j.jse.2024.03.059","article-title":"After primary shoulder arthroplasty appropriate vancomycin antibiotic prophylaxis does not lead to increased infectious complications when compared to cefazolin","volume":"33","author":"Marigi","year":"2024","journal-title":"J Shoulder Elbow Surg"},{"key":"10.1016\/j.arth.2025.04.079_bib28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.2340\/17453674.2023.16907","article-title":"No difference in risk of revision due to infection between clindamycin and cephalosporins as antibiotic prophylaxis in cemented primary total knee replacements: a report from the Norwegian Arthroplasty Register 2005-2020","volume":"94","author":"Pawloy","year":"2023","journal-title":"Acta Orthop"},{"key":"10.1016\/j.arth.2025.04.079_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40457","article-title":"Incidence, microbiological studies, and Factors associated with prosthetic joint infection after total knee arthroplasty","volume":"6","author":"Weinstein","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.arth.2025.04.079_bib31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.arth.2025.04.079_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.arth.2020.10.003","article-title":"Tranexamic acid administration is associated with a decreased odds of prosthetic joint infection following primary total hip and primary total knee arthroplasty: a national database analysis","volume":"36","author":"Hong","year":"2021","journal-title":"J Arthroplasty"},{"key":"10.1016\/j.arth.2025.04.079_bib33","doi-asserted-by":"crossref","first-page":"732.e1","DOI":"10.1016\/j.cmi.2016.05.004","article-title":"Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study","volume":"22","author":"Benito","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.arth.2025.04.079_bib34","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0741-5214(92)70011-9","article-title":"Cefuroxime versus cefazolin as prophylaxis in vascular surgery","volume":"15","author":"Edwards","year":"1992","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.arth.2025.04.079_bib35","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1056\/NEJMoa2301401","article-title":"Trial of vancomycin and cefazolin as surgical prophylaxis in arthroplasty","volume":"389","author":"Peel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arth.2025.04.079_bib36","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.jaci.2022.08.028","article-title":"Drug allergy: a 2022 practice parameter update","volume":"150","author":"Khan","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Journal of Arthroplasty"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325004723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883540325004723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:05:48Z","timestamp":1758189948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883540325004723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0883540325004723"],"URL":"https:\/\/doi.org\/10.1016\/j.arth.2025.04.079","relation":{},"ISSN":["0883-5403"],"issn-type":[{"value":"0883-5403","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefazolin Is Associated With a Lower Periprosthetic Joint Infection Risk than Alternative Antibiotic Regimens Following Total Hip Arthroplasty","name":"articletitle","label":"Article Title"},{"value":"The Journal of Arthroplasty","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arth.2025.04.079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}